We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Hydrogel Repairs Torn Cartilage

By HospiMedica International staff writers
Posted on 20 Aug 2008
A new hydrogel that promotes cartilage repair has potential applications in orthopedics, wound care, and other clinical disciplines involving connective tissue.

The innovative hydrogel is intended as a less invasive alternative to surgery, putting off joint replacement surgery for at least five years. More...
The new gel is composed almost entirely of water, yet can thicken to produce a substance 100-1000 times stronger than similar gels. This is due to the fact that it is composed of two very long elastic-like molecules of polyvinyl alcohol (PVOH) that form strong covalent bonds with each other to form a three-dimensional (3D) lattice network that holds the water. By adjusting the number of covalent bonds, the properties of the gel can be manipulated to make it thick, thin, or sticky. This is achieved by using a unique cross-linker (PD2000) that is capable of bonding with a range of copolymers to form materials with distinct combinations of useful properties. This also grants the gel the capability to hold molecules of other substances, whether water-soluble or not (such as oil).

The hydrogel is non-toxic, intrinsically bacteriostatic, and can be used as a medium for tissue growth. The hygrostatic gel can be extruded into films, can be used to generate microemulsions, is temperature and radiation resistant, and can be used for sustained release of incorporated substances due to zero-order kinetics. A feature of the technology includes physical and chemical properties capable of forming a wide range of hydrogels with different physicochemical properties, including the ability to vary the physical form from liquid to solids with very high water content with very high mechanical strength maintained. The cross-linking reaction can be completed unaffected by the presence of other substances, and is reversible when desired. The gel was developed by researchers at the University of Bradford (UK) and Advanced Gel Technology (AGT, Bradford, UK), a Bradford University spin-out company.

"The potential for improved quality of life is huge. The number of people suffering from cartilage problems is increasing every year,” said Peter Twigg, Ph.D., lead researcher of the cartilage repair project at the University of Bradford. "Total joint replacement is very successful, but may not be appropriate for younger, more active people. They are often encouraged to put off surgery until the pain is disabling, but a conservative replacement treatment could relieve pain and restore function at a much earlier stage.”

Related Links:
University of Bradford
Advanced Gel Technology


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.